Mico BioMed Reports Operating Loss of 19.3 Billion KRW Last Year... Continued Deficit
Mico Biomed announced that its operating loss last year was 19.3 billion KRW, continuing its deficit. The net loss for the period was 25.7 billion KRW.
Hot Picks Today
[Exclusive] "This Is Why Samsung Stands Out"... Onnuri Gift Certificates Replace Loyalty Points
- "Seoul's Nightlife Transformed: Why Fewer People Ride the Subway After Midnight"
- Drunk Man in His 30s Drives 1.5 km Dragging Substitute Driver to Death... Bereaved Family: "No Apology"
- "What Would Those Ignorant People Know? They Won't Notice If We Don't Give Them Ballots"…Drama Scene Resurfaces Amid Ballot Shortage Crisis
- 'Youngest' Koo Kwangmo Fills Water Glasses, 'Eldest' Chey Taewon Pours Drinks... Toast: "Go Korea! SK, LG, Naver"
The company explained that sales in the molecular diagnostics sector (PCR devices and reagents, etc.) and the immunodiagnostics sector (RDT kits, etc.) decreased due to the transition to the COVID-19 endemic phase.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.